Standard effective doses for proliferative tumours

Physics in Medicine and Biology

Volumn 45, Issue 10, 2000, Pages

  Dasu, Iuliana Livia ^a   Dasu, Alexandru ^a   Denekamp, Juliana ^a   Fowler, Jack F ^b  

^a UMEÅ UNIVERSITY   (Sweden)

^b University of Wisconsin Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER GROWTH; CANCER RADIOTHERAPY; DOSIMETRY; LETTER; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; COMPUTER ASSISTED RADIOTHERAPY; HUMAN; METHODOLOGY; NEOPLASM; NOTE; THEORETICAL MODEL; TIME;

HUMANS; MODELS, THEORETICAL; NEOPLASMS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; TIME FACTORS;

EID: 0033773034     PISSN: 00319155     EISSN: None     Source Type: Journal    
DOI: 10.1088/0031-9155/45/10/101     Document Type: Letter

References (9)

1. The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: A multicenter analysis
2. Mucosal regeneration during radiotherapy. Trans Tasman Radiation Oncology Group (TROG)
3. The linear-quadratic formula and progress in fractionated radiotherapy
4. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: Final analysis of a randomized trial of the EORTC cooperative group of radiotherapy
5. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: Results of the EORTC 22851 randomized trial
6. Standard effective doses for proliferative tumours
7. Randomized clinical trial on accelerated 7 days per week fractionation in radiotherapy for head and neck cancer. Preliminary report on acute toxicity
8. Randomised multicentre trials of CHART vs conventional radiotherapy in head and neck and non-small-cell lung cancer: An interim report. CHART Steering Committee
9. Local control of oropharyngeal carcinoma after two accelerated hyperfractionation radiation therapy schemes